SCHEMBL20428951

SCHEMBL20428951

CC(C)CNC(=O)c1nc(Br)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.49
RAB9A P51151 7/20 0.47
NPC1 O15118 5/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HPGD P15428 5/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
MLYCD O95822 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
TAS1R2 Q8TE23 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15204826 0.82 KMT2A (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL162901 0.82 KMT2A (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL17711400 0.78 GRM5 (0.47) GRM5
SCHEMBL15811833 0.78 GRM5 (0.47) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL15838913 0.78 GRM5 (0.47) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL15811834 0.78 GRM5 (0.47) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL231752 0.78 GRM5 (0.53) GRM5NPC1ALDH1A1GAALMNA
SCHEMBL1476030 0.78 GRM5 (0.55) GRM5RAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL20429001 0.77 GAA (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1KMT2A
SCHEMBL20428982 0.77 KMT2A (0.40) RAB9ANPC1SMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354651-A1 TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF ROR-GAMMA-T Janssen Pharmaceutica N.V. (BE) 2018-08-01 EP disclosed